In the cancer background, most of the histone‐modified enzymes work as a carcinogenic factor, but there are also exceptions, such as HBO1 of the HAT family can inhibit cancer in GC, CRC, and AML. This evidence concerns the gene TMPRSS11D and acute myeloid leukemia.